SS
FATE icon

SBI Securities’s Fate Therapeutics FATE Stock Holding History

SBI Securities’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Hold
1,172
– – ﹤0.01% 2379
2026
Q1 		$1.41K Sell
1,172
-150
-11% -$183 ﹤0.01% 2529
2025
Q4 		$1.3K Sell
1,322
-15
-1% -$18 ﹤0.01% 2546
2025
Q3 		$1.69K Sell
1,337
-99
-7% -$107 ﹤0.01% 2481
2025
Q2 		$1.61K Buy
1,436
+707
+97% +$822 ﹤0.01% 2481
2025
Q1 		$576 Sell
729
-42
-5% -$51 ﹤0.01% 2814
2024
Q4 		$1.27K Buy
+771
New +$1.94K ﹤0.01% 2500

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Securities's FATE Position: Q2 2026 in Review

SBI Securities held its Fate Therapeutics (FATE) position steady in Q2 2026 at 1,172 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

SBI Securities first reported a position in FATE in Q4 2024 and has held it in 7 quarters since. 155 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • SBI Securities held 1,172 shares of Fate Therapeutics worth $3.16K as of Q2 2026.
  • SBI Securities left its Fate Therapeutics share count unchanged in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2379 holding.
  • SBI Securities first reported a position in Fate Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 155 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.